This multidisciplinary conference will integrate emerging technologies and immunobiology to advance genetic engineering of immune cells to treat cancer and other pathologies. Main themes include strategies to identify novel immune targets, enhance the function of synthetic and natural antigen receptors, and genetically engineer and edit T cells and their precursors.
The conference will also cover mechanisms of resistance to cell-based immunotherapies and antigen escape in the context of the tumor microenvironment, and how to overcome these challenges. We will also explore the engineering of alternative cell types, including NK cells and pluripotent stem cell-derived immune cells, and their potential to overcome current barriers to immunotherapy.
As a joint meeting with the Keystone Symposia on “Precision Genome Engineering,” all attendees will gain access to both meetings and joint sessions to promote cross-disciplinary collaboration and innovation in tools, technologies and applications for cellular therapies.
Program Highlights:
- Hematopoietic and Pluripotent Stem Cell Editing (joint session)
- T-Cell Engineering
- CARs and TCRs
- Immune and Antigen Escape
- T-Cell Exhaustion
- Epigenetics and Metabolism Re-Wiring
- Other than Conventional T-Cells
- Target Discovery
Register Now
See what editors from Cell Press and other leading journals have to say about the meeting!
Connect with these editors in-person or virtually at the Emerging Cellular Therapies meeting!
Register Now
for in-person or virtual attendance
helminths
Q/A with "Helminths: New Insights from Immunity to Global Health" co-organizer Dr. Nicola Harris
"Helminths are perhaps the most successful parasites on the planet," says Dr. Nicola Harris,...
